We are live on
!
Find out more
DCM
Dupont Capital Management Portfolio holdings
AUM
$2.18M
1-Year Est. Return
50.81%
This Fund
S&P 500
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+50.81%
3 Year Est. Return
+136.7%
5 Year Est. Return
+194.47%
10 Year Est. Return
+665.34%
AUM
$6.11B
AUM Growth
-$87.3M
(-1.4%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
37.44%
Holding
730
New
108
Increased
158
Reduced
191
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$18M |
| 2 |
NetApp
NTAP
|
+$18M |
| 3 |
Goldman Sachs
GS
|
+$17.9M |
| 4 |
American Airlines Group
AAL
|
+$17.9M |
| 5 |
Gilead Sciences
GILD
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$182M |
| 2 |
Pfizer
PFE
|
+$36.6M |
| 3 |
POSCO
PKX
|
+$24.9M |
| 4 |
TSMC
TSM
|
+$22.1M |
| 5 |
AGN
Allergan Inc
AGN
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 23.59% |
| 2 | Technology | 10.93% |
| 3 | Financials | 9.74% |
| 4 | Healthcare | 7.61% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENOC
551
DELISTED
EnerNOC, Inc.
ENOC
| $619K | 0.01% |
+32,670
| New | +$659K |
|
|
ELP
552
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $607K | 0.01% |
99,053
-1,670
| -2% | -$9.87K |
|
553
Opko Health
OPK
$1.04B
| $602K | 0.01% |
+68,060
| New | +$594K |
|
|
IMOS
554
ChipMOS TECHNOLOGIES
IMOS
$1.84B
| $595K | 0.01% |
22,374
-16,391
| -42% | -$412K |
|
|
ALOG
555
DELISTED
Analogic Corp
ALOG
| $595K | 0.01% |
7,605
| – | – |
|
|
CEO
556
DELISTED
CNOOC Limited
CEO
| $582K | 0.01% |
+3,246
| New | +$549K |
|
557
M/I Homes
MHO
$3.74B
| $581K | 0.01% |
+23,950
| New | +$545K |
|
558
Ducommun
DCO
$2.94B
| $577K | 0.01% |
22,074
| – | – |
|
559
Melco Resorts & Entertainment
MLCO
$2.12B
| $574K | 0.01% |
16,080
| – | – |
|
560
Stride
LRN
$3.33B
| $572K | 0.01% |
+23,750
| New | +$556K |
|
|
STML
561
DELISTED
Stemline Therapeutics, Inc.
STML
| $569K | 0.01% |
+38,810
| New | +$595K |
|
|
LION
562
DELISTED
Fidelity Southern Corporation
LION
| $566K | 0.01% |
43,575
-13,980
| -24% | -$189K |
|
563
Trimble
TRMB
$13.6B
| $562K | 0.01% |
15,210
-19,800
| -57% | -$740K |
|
564
Realty Income
O
$58.6B
| $560K | 0.01% |
+13,003
| New | +$543K |
|
565
Emergent Biosolutions
EBS
$229M
| $554K | 0.01% |
24,661
| – | – |
|
|
INSY
566
DELISTED
Insys Therapeutics, Inc.
INSY
| $549K | 0.01% |
35,138
-2
| -0% | -$32 |
|
567
LG Display
LPL
$3.36B
| $546K | 0.01% |
34,612
+4,000
| +13% | +$55.4K |
|
568
TransDigm Group
TDG
$67.6B
| $543K | 0.01% |
3,244
| – | – |
|
569
Celestica
CLS
$39.7B
| $514K | 0.01% |
40,916
+5,000
| +14% | +$57.6K |
|
570
PVH
PVH
$4.02B
| $514K | 0.01% |
4,407
| – | – |
|
571
PACCAR
PCAR
$69.1B
| $511K | 0.01% |
12,204
| – | – |
|
|
SNBR
572
DELISTED
Sleep Number
SNBR
| $494K | 0.01% |
23,907
-41,550
| -63% | -$784K |
|
573
Neurocrine Biosciences
NBIX
$16.8B
| $490K | 0.01% |
32,990
-5,890
| -15% | -$83.1K |
|
|
MRSH
574
Marsh
MRSH
$91B
| $485K | 0.01% |
9,364
| – | – |
|
575
Manitowoc
MTW
$681M
| $482K | 0.01% |
16,181
-8,552
| -35% | -$227K |
|
Similar funds
BPM
DILIH
WH
DF
HGCK
1IC
KI
SH
Dupont Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Dupont Capital Management held 730 positions worth $6.11B, down 1.4% from $6.19B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Dupont Capital Management withdrew a net $283M in Q2 2014, closing 93 positions and reducing 191 holdings. Its most notable exit was Allergan Inc, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Materials at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Dupont Capital Management opened a new position in NetApp worth $18.3M.
- Dupont Capital Management's largest Q2 2014 buy was NetApp: 501,199 shares worth $18.3M.
- Dupont Capital Management added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $18M increase.
- Dupont Capital Management's biggest Q2 2014 reduction was iShares MSCI EAFE ETF, cutting an estimated $182M.
- Dupont Capital Management fully exited Allergan Inc in Q2 2014, selling an estimated $19.3M.
- Dupont Capital Management's ten largest holdings make up 37% of its $6.11B portfolio in Q2 2014.
- Dupont Capital Management opened 108 new positions and closed 93 in Q2 2014.
- Dupont Capital Management's portfolio value fell 1.4% quarter-over-quarter to $6.11B.
Based on Dupont Capital Management's 13F filing for Q2 2014, filed 11 Aug 2014.